Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-19 Purchase |
2024-12-19 9:51 pm |
enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer |
12,000 | $2.55 | $30,600 | 222,236 (Direct) |
View |
| 2022-06-27 Purchase |
2022-06-28 4:05 pm |
enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer |
2,500 | $3.8 | $9,500 | 210,236 (Direct) |
View |
| 2021-11-19 Purchase |
2021-11-19 5:27 pm |
enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW CEO |
2,000 | $7.43 | $14,860 | 7,736 (Direct) |
View |
| 2021-11-16 Purchase |
2021-11-18 4:24 pm |
enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW CEO |
2,000 | $7.87 | $15,740 | 5,736 (Direct) |
View |
| 2021-05-18 Purchase |
2021-05-19 8:20 pm |
Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW Chief Executive Officer |
3,000 | $5.47 | $16,410 | 3,736 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-18 Option Award |
2024-12-20 8:33 pm |
N/A 2034-12-18 |
enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-12-05 Option Award |
2023-12-07 5:05 pm |
N/A 2033-12-05 |
enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 6:27 pm |
N/A 2031-11-30 |
enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer |
549,781 | $0 | 557,517 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 9:56 pm |
N/A 2031-02-18 |
Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW Chief Executive Officer |
838,000 | $0 | 838,000 (Direct) |
View |
| 2020-07-18 Option Award |
2020-07-21 9:55 pm |
N/A 2030-07-18 |
Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW CEO |
1,080,207 | $0 | 1,080,207 (Direct) |
View |
| 2020-07-18 Other |
2020-07-21 9:55 pm |
2018-04-26 2028-04-26 |
Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW CEO |
1,080,207 | $0 | 1,080,207 (Direct) |
View |
| 2020-07-18 Option Award |
2020-07-21 9:55 pm |
N/A 2030-07-18 |
Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW CEO |
1,000,000 | $0 | 1,000,000 (Direct) |
View |